5% stakes
Soleus Capital Master Fund
Institution
- 5% stake reports
- 36
- 5% stake stocks
- 18
- Latest report
- 26/08/31
5% stake reports
| Stock | ||
|---|---|---|
| Evolus EOLS08/31 | 5.3%3,480,000 sh | First report |
| Processa Pharmaceuticals PCSA08/18 | 5.8%160,943 sh | First report |
| Inspire Medical Systems INSP08/13 | 6.7%1,931,436 sh | +1.6pp |
| Palisade Bio PALI08/13 | 7.5%13,063,687 sh | +2.1pp |
| Rigel Pharmaceuticals RIGL08/13 | 9.9%1,843,504 sh | +4.7pp |
| Vericel VCEL08/13 | 2.8%1,458,882 sh | −2.2pp |
| Immunic IMUX08/13 | 4.9%679,200 sh | −0.6pp |
| Cerus CERS08/13 | 1.2%2,500,000 sh | −3.9pp |
| Biodesix BDSX06/18 | 5.1%525,241 sh | +1.0pp |
| Palisade Bio PALI05/27 | 5.4%9,353,687 sh | First report |
| Inspire Medical Systems INSP05/27 | 5.1%1,470,748 sh | First report |
| NovoCure NVCR05/08 | 9.1%10,492,391 sh | +1.5pp |
| Jasper Therapeutics JSPR05/08 | 1%276,312 sh | −9.0pp |
| Geron GERN05/08 | 6.5%41,508,659 sh | +1.3pp |
| Context Therapeutics CNTX05/08 | 7.6%6,963,141 sh | +2.4pp |
| Biodesix BDSX05/08 | 4.1%416,599 sh | −2.2pp |
| Rigel Pharmaceuticals RIGL05/07 | 5.2%968,108 sh | +1.5pp |
| Vericel VCEL04/01 | 5%2,549,079 sh | First report |
| Cerus CERS03/24 | 5.1%9,828,700 sh | First report |
| Pulmonx LUNG03/09 | 6.5%2,665,100 sh | First report |
